Cargando…
A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer
RG7787 is a re-engineered mesothelin-targeted immunotoxin with reduced immunogenicity composed of a humanized anti-mesothelin Fab fragment and a B-cell epitope silenced 24 kD fragment of Pseudomonas exotoxin A. High prevalence of mesothelin-positive cases and a large unmet medical need make ovarian...
Autores principales: | Kollmorgen, Gwendlyn, Palme, Klara, Seidl, Annette, Scheiblich, Stefan, Birzele, Fabian, Wilson, Sabine, Clemens, Christian, Voss, Edgar, Kaufmann, Martin, Hirzel, Klaus, Rieder, Natascha, Krippendorff, Ben-Fillippo, Herting, Frank, Niederfellner, Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741731/ https://www.ncbi.nlm.nih.gov/pubmed/29273809 http://dx.doi.org/10.1038/s41598-017-17329-7 |
Ejemplares similares
-
Acquired Resistance to Antibody-Drug Conjugates
por: Collins, Denis M., et al.
Publicado: (2019) -
Structural Requirements for Cub Domain Containing Protein 1 (CDCP1) and Src Dependent Cell Transformation
por: Kollmorgen, Gwendlyn, et al.
Publicado: (2012) -
Quantification of recombinant immunotoxin delivery to solid tumors allows for direct comparison of in vivo and in vitro results
por: Mason-Osann, Emily, et al.
Publicado: (2015) -
Predicting the F(ab)-mediated effect of monoclonal antibodies in vivo by combining cell-level kinetic and pharmacokinetic modelling
por: Krippendorff, Ben-Fillippo, et al.
Publicado: (2012) -
Anti-BCMA Immunotoxins: Design, Production, and Preclinical Evaluation
por: Bera, Tapan K.
Publicado: (2020)